艾斐智药
科学智能
艾斐智药源于清华 AIR，以 DrugCLIP 等算法把大规模分子筛选转化为高效检索问题。其 AI 药物研发路线从疾病与靶点研究延伸至分子设计，探索更连续的发现流程。
Originating from Tsinghua AIR, AIPher uses algorithms including DrugCLIP to turn large-scale molecular screening into a retrieval problem. Its broader drug-discovery work connects disease and target research with molecular design.
